Search

everythinglearnresearchcommunity

for

Search:↓

Neoadjuvant chemotherapy followed by surgery leads to fewer severe complications and better quality of life than immediate surgery in advanced ovarian cancer patients with high tumor load.

Baricitinib is generally safe for long-term use in treating severe alopecia areata.

Further testing of paclitaxel poliglumex for this cancer treatment is not justified.

Safusidenib erbumine shows promise as a treatment for certain brain tumors, but mild side effects like hair loss need attention.

Baricitinib was effective in treating hair loss in adults with alopecia areata according to patient feedback.

St. John’s wort changes how finasteride works in the body, possibly affecting its effectiveness.

Topical bexarotene 1% gel might help regrow hair in alopecia areata and is generally safe.

Weekly bicalutamide is safe and effective, with 50 mg/week recommended.

MK-0773 safely increased muscle mass but did not improve muscle strength or function in elderly women with sarcopenia.

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

Both vaginal testosterone cream and Estring effectively manage vaginal dryness in women with early-stage breast cancer on aromatase inhibitors.

Sacituzumab govitecan improves quality of life and symptoms in breast cancer patients, except for causing more diarrhea.

The treatment combination is effective and generally safe for lung cancer.

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.

5% minoxidil foam is effective and safe for hair regrowth in women with hair loss.

Deucravacitinib did not significantly improve hair regrowth in alopecia areata patients.

The 0.05% dutasteride topical solution effectively promotes hair growth with fewer side effects than oral treatments.

The gene therapy showed significant wound healing and was safe for treating severe RDEB.

Injections of special skin cells showed potential in treating hair loss, with some participants experiencing increased hair density.

Pegylated liposomal doxorubicin is as effective as conventional doxorubicin but causes fewer heart problems and side effects.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

Docetaxel and oxaliplatin are effective and have manageable side effects for recurrent platinum-sensitive ovarian cancer.

Topical finasteride is an effective and safer treatment for male hair loss.

The drug TGU was ineffective against small cell lung cancer and caused significant bone marrow suppression.

Adding dutasteride to therapy may improve treatment for advanced salivary duct cancer.

Neoadjuvant endocrine therapy led to a better future outlook than chemotherapy, with no major quality of life differences.

Karunjchirakam Chooranam significantly improved symptoms in most PCOS cases.

Tavaborole is a safe and effective toenail fungus treatment, with the 5% solution being the best option.

Etanercept is safe and may help improve hidradenitis suppurativa, but more research is needed.

The treatment combining docetaxel, cisplatin, and 5-FU is feasible and effective for advanced head and neck cancer.